✦ LIBER ✦

PRS31 Economic Evaluation of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) from the Public Payer Perspective in Brazil

✍ Scribed by Suzuki, C.; Silva, N.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS14 Estimating the Budget Impact of In

✍ Suzuki, C.; Silva, N.L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PRS15 Estimating the Budget Impact of In

✍ Suzuki, C.; Silva, N.L. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PRS26 Economic Evaluation of Omalizumab

✍ Suzuki, C.; Pepe, C.; Silva, N.L. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS40 Economic Evaluation of Etanercept

✍ R.A. Fernandes; M.L.S. Takemoto; A.C.M. Tolentino; M.M.S. Takemoto; P.M.L. Santo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PSY25 Etanercept in Early Rheumatoid Art

✍ Takemoto, M.; Fernandes, R.A.; Fujii, R.K.; Mould, J.; Tang, B. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Economic Burden in Direct Costs of Chron

✍ Malhan, S.; Polatli, M.; Ozturk, C.; Oksuz, E.; Durgun, B.; Eray, O. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB